News
The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...
Over the past decade, several novel immunotherapies have transformed the treatment landscape of relapsed or refractory B-cell acute lymphoblastic leukaemia. In the pivotal TOWER trial, blinatumomab—a ...
Infections that could trigger severe brain inflammation and respiratory disease have been discovered in bats in China. And ...
SCIENTISTS have raised “urgent concerns” over new viruses discovered in bats which have the potential to spill over into ...
Pete Wicks recently claimed that he caught a serious disease after starring in a 2018 show that saw him lose a dramatic ...
From 2018 to 2020, Ebola spread again from the DRC to Uganda. There have been further outbreaks in Gabon, South Africa, Côte ...
GENEVA ― Following a systematic review and meta-analysis of randomized clinical trials of the disease's therapeutics, the World Health Organization (WHO) has made strong recommendations for two ...
The newly approved treatment targets Zaire Ebola virus. In a study of 382 adults and children that received it, it cut the risk of dying after 28 days from 51% to 33.8%.
First Ebola treatment approved by FDA Regeneron’s antibody cocktail developed using the same technology as its COVID-19 treatment by Megha Satyanarayana ...
Recently, the FDA formally approved the first vaccine to prevent the Ebola virus. The advance comes at a crucial time, as Democratic Republic of Congo is suffering an outbreak that has lasted over ...
Ebola is dangerous but it is also curable with correct treatment, said Dr. Jean-Jacques Muyembe, director of Congo’s National Institute for Biomedical Research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results